The Brydon Group Leads Majority Investment in Renesan and Visonex

August 14, 2023

The Brydon Group led a majority investment to combine Renesan and Visonex, two U.S.-based providers of cloud-based software for dialysis clinics. The combined company will be led by executives from both firms (Chris Sigala as CEO) and will use the new capital to accelerate product development and expand healthcare IT offerings for kidney care providers.

Targets
Renesan, Visonex
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.